Corbus Pharmaceuticals
CRBP
CRBP
81 hedge funds and large institutions have $144M invested in Corbus Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
8% less funds holding
Funds holding: 88 → 81 (-7)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
76% less call options, than puts
Call options by funds: $418K | Put options by funds: $1.71M
Holders
81
Holding in Top 10
1
Calls
$418K
Puts
$1.71M
Top Buyers
| 1 | +$14M | |
| 2 | +$13.2M | |
| 3 | +$575K | |
| 4 |
Morgan Stanley
New York
|
+$369K |
| 5 |
VEA
Virtus ETF Advisers
New York
|
+$336K |
Top Sellers
| 1 | -$4.26M | |
| 2 | -$4M | |
| 3 | -$2.84M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.66M |
| 5 |
PA
Perceptive Advisors
New York
|
-$1.42M |